Barbara Küppers-Munther

Dr. Barbara Küppers-Munther

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2015 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
AAAnnika Asplund
Annika Asplund
APArvind Pradip
Arvind Pradip
MGMariska van Giezen
Mariska van Giezen
AAAnders Aspegren
Anders Aspegren
HCHelena Choukair
Helena Choukair
BKBarbara Küppers-Munther
Barbara Küppers-Munther

Verified
Journal Article
Open access
PDF file
GHGustav Holmgren
Gustav Holmgren
BUBenjamin Ulfenborg
Benjamin Ulfenborg
AAAnnika Asplund
Annika Asplund
KTKarin Toet
Karin Toet
CAChristian X Andersson
Christian X Andersson
JSJane Synnergren
Jane Synnergren
There is a strong anticipated future for human induced pluripotent stem cell-derived hepatocytes (hiPS-HEP), but so far, their use has been limited due to insufficient functionality. We investigated the potential of hiPS-HEP as an in vitro model for metabolic diseases by combining transcriptomics with multiple functional assays. The transcriptomics analysis revealed that 86% of the genes were expressed at similar levels in hiPS-HEP as in human primary hepatocytes (hphep). Adult characteristics of the hiPS-HEP were confirmed by the presence of important hepatocyte features, e.g., Albumin secretion and expression of major drug metabolizing genes. Normal energy metabolism is crucial for modeling metabolic diseases, and both transcriptomics data and functional assays showed that hiPS-HEP were similar to hphep regarding uptake of glucose, low-density lipoproteins (LDL), and fatty acids. Importantly, the inflammatory state of the hiPS-HEP was low under standard conditions, but in response to lipid accumulation and ER stress the inflammation marker tumor necrosis factor α (TNFα) was upregulated. Furthermore, hiPS-HEP could be co-cultured with primary hepatic stellate cells both in 2D and in 3D spheroids, paving the way for using these co-cultures for modeling non-alcoholic steatohepatitis (NASH). Taken together, hiPS-HEP have the potential to serve as an in vitro model for metabolic diseases. Furthermore, differently expressed genes identified in this study can serve as targets for future improvements of the hiPS-HEP.

1 September 2015 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
SJSara Johansson
Sara Johansson
GHGustav Holmgren
Gustav Holmgren
BKBarbara Küppers-Munther
Barbara Küppers-Munther
CECatharina Ellerström
Catharina Ellerström
PSPeter Sartipy
Peter Sartipy
JEJosefina Edsbagge
Josefina Edsbagge

14 November 2019 in Preprints.org
Verified
Preprint
Open access
PDF file
GHGustav Holmgren
Gustav Holmgren
BUBenjamin Ulfenborg
Benjamin Ulfenborg
AAAnnika Asplund
Annika Asplund
KTKarin Toet
Karin Toet
CAChristian X Andersson
Christian X Andersson
JSJane Synnergren
Jane Synnergren
There is a strong anticipated future for human pluripotent stem cell-derived hepatocytes (hiPS-HEP), but so far their use has been limited due to insufficient functionality. We investigated the potential of hiPS-HEP as an in vitro model for metabolic diseases by combining transcriptomics with multiple functional assays. The transcriptomics analysis revealed that 86% of the genes were expressed at similar levels in hiPS-HEP as in human primary hepatocytes (hphep). Adult characteristics of the hiPS-HEP were confirmed by the presence of important hepatocyte features, e.g. Albumin secretion and expression of major drug metabolizing genes. Normal energy metabolism is crucial for modeling metabolic diseases, and both transcriptomics data and functional assays showed that hiPS-HEP were similar to hphep regarding uptake of glucose, LDL and fatty acids. Importantly, the inflammatory state of the hiPS-HEP was low under standard conditions, but in response to lipid accumulation and ER stress the inflammation marker TNFα was upregulated. Furthermore, hiPS-HEP could be co-cultured with primary hepatic stellate cells both in 2D and in 3D spheroids, paving the way for using these co-cultures for modeling NASH. Taken together, hiPS-HEP have the potential to serve as an in vitro model for metabolic diseases. Furthermore, differently expressed genes identified in this study can serve as targets for future improvements of the hiPS-HEP.

1 October 2015 in Toxicology Letters
Verified
Journal Article
Open access
PGPaulo Godoy
Paulo Godoy
WSW. Schmidt-Heck
W. Schmidt-Heck
KNK. Natarajan
K. Natarajan
BLB. Lucendo-Villarin
B. Lucendo-Villarin
DSD. Szkolnika
D. Szkolnika
Jan G HengstlerJan G Hengstler
Jan G Hengstler